Novartis creates online resource for practitioners

DORVAL, Que. – Novartis Pharmaceuticals Canada Inc. has launched the Novartis Pro Portal, a comprehensive digital resource for healthcare practitioners. Developed in collaboration with over 120 physicians, the Pro gives healthcare professionals access to tailored, real-time support, digital knowledge and resources to improve their daily practice and drive progress for patients across Canada.

As the pandemic accelerated a digital-first approach to patient care among healthcare practitioners, Novartis has heard from physicians that they want faster access to resources, in a real-time, all-in-one central digital location.

A vehicle for advancing medical progress, the Novartis Pro Portal responds to this need, reimagining how knowledge is exchanged between the pharmaceutical industry and healthcare practitioners, for the benefit of patients. With this new digital resource, Novartis gives healthcare practitioners fast access to a wide and valuable range of features to enhance their practice and patient care – whenever and wherever they need them.

“The Novartis Pro Portal is certain to be an invaluable tool for the physicians everywhere, helping to streamline access to essential support and medical information,” said Dr. Tara Lad (pictured), MD FRCPC general neurologist with a special interest in Multiple Sclerosis. “Having communication options on demand gives me easier and faster access to the resources I need, when I need them, helping give healthcare professionals like me back one of our most valuable commodities – time.”

The Novartis Pro Portal provides quick and easy access to digital content and services for physicians across five sections (Products; Learning Resources; Practice Support; Therapeutic Area; and Community) and consolidates medical information – which is often spread across many sources – into one centralized location. The result is a more efficient knowledge-gathering experience for physicians, allowing them to spend more time with patients.

“Developing the Novartis Pro Portal in collaboration with more than 120 healthcare practitioners was essential for Novartis,” said Ben Massingham, vice-president of transformation and innovation. “We wanted to make sure we got the Pro Portal right – creating something that healthcare practitioners wanted and needed, rather than something we hoped they would need. The Pro Portal marks another innovation milestone from Novartis that supports healthcare practitioners and their patients, while addressing gaps in care.”

The Novartis Pro Portal leverages a live and on-demand Scientific Engagement Manager, on standby Monday to Friday from 9:00-17:00 EST. The Manager is equipped to respond to medical questions within the therapeutic area and to guide users to the information they require within the portal, including interactive webinar sessions and on-demand podcasts and videos.

The Novartis Pro Portal will launch first with a focus on neuroscience, with rheumatology as the next therapeutic area in line to be added in Fall 2022. Healthcare practitioners can register for their access to the Novartis Pro Portal now, at https://bit.ly/3NnbGJH.

About Novartis in Canada
Novartis Pharmaceuticals Canada, a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. Over the last 5 years, our average annual research and development investment in Canada was $47 million. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada employs approximately 1,000 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment. Novartis is recognized as a Great Place to Work, ranked among the Top 50 Best Workplaces in the country and is proudly named on the 2021 Best Workplaces for Women in Canada and Best Workplace for Mental Wellness lists. For further information, please visit www.novartis.ca.